Specifically, in the Taylor et al. [8] Memorial Sloan-Kettering Cancer Center (MSKCC) and TCGA Prostate Adenocarcinoma (TCGA-PRAD) PCa cohorts [9], the retinoic acid receptor gamma (NR1B3/RARG, encodes RARγ) and glucocorticoid receptor (NR3C1/GR) were significantly and uniquely downregulated compared to other cancers. Here, RARG is linked to prostate adenocarcinoma.